Nonclinical Studies Of Abuse Potential With Dual Orexin-Receptor Antagonists: Concordance With Real-World Use

Belsomra (suvorexant) - Merck (MSD)

Quviviq (daridorexant) - Idorsia, Syneos Health, Nxera Pharma, Simcere

Dayvigo (lemborexant) - Eisai

temazepam - Generic mfg.

Margaret Moline 1; Jocelyn Y. Cheng 1; Jack E. Henningfield 2; Mark A. Sembower 2; Steve Pype 2; August R. Buchhalter 2

May 30, 2024